Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel therapeutic targets in depression: minocycline as a candidate treatment.
Soczynska JK, Mansur RB, Brietzke E, Swardfager W, Kennedy SH, Woldeyohannes HO, Powell AM, Manierka MS, McIntyre RS. Soczynska JK, et al. Among authors: woldeyohannes ho. Behav Brain Res. 2012 Dec 1;235(2):302-17. doi: 10.1016/j.bbr.2012.07.026. Epub 2012 Aug 10. Behav Brain Res. 2012. PMID: 22963995 Review.
Advancing biomarker research: utilizing 'Big Data' approaches for the characterization and prevention of bipolar disorder.
McIntyre RS, Cha DS, Jerrell JM, Swardfager W, Kim RD, Costa LG, Baskaran A, Soczynska JK, Woldeyohannes HO, Mansur RB, Brietzke E, Powell AM, Gallaugher A, Kudlow P, Kaidanovich-Beilin O, Alsuwaidan M. McIntyre RS, et al. Among authors: woldeyohannes ho. Bipolar Disord. 2014 Aug;16(5):531-47. doi: 10.1111/bdi.12162. Epub 2013 Dec 16. Bipolar Disord. 2014. PMID: 24330342 Review.
The prevalence and illness characteristics of DSM-5-defined "mixed feature specifier" in adults with major depressive disorder and bipolar disorder: Results from the International Mood Disorders Collaborative Project.
McIntyre RS, Soczynska JK, Cha DS, Woldeyohannes HO, Dale RS, Alsuwaidan MT, Gallaugher LA, Mansur RB, Muzina DJ, Carvalho A, Kennedy SH. McIntyre RS, et al. Among authors: woldeyohannes ho. J Affect Disord. 2015 Feb 1;172:259-64. doi: 10.1016/j.jad.2014.09.026. Epub 2014 Oct 12. J Affect Disord. 2015. PMID: 25451425
Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study.
Mansur RB, Ahmed J, Cha DS, Woldeyohannes HO, Subramaniapillai M, Lovshin J, Lee JG, Lee JH, Brietzke E, Reininghaus EZ, Sim K, Vinberg M, Rasgon N, Hajek T, McIntyre RS. Mansur RB, et al. Among authors: woldeyohannes ho. J Affect Disord. 2017 Jan 1;207:114-120. doi: 10.1016/j.jad.2016.09.056. Epub 2016 Oct 1. J Affect Disord. 2017. PMID: 27721184
A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder.
Cha DS, Best MW, Bowie CR, Gallaugher LA, Woldeyohannes HO, Soczynska JK, Lewis G, MacQueen G, Sahakian BJ, Kennedy SH, Lui JP, Mansur RB, McIntyre RS. Cha DS, et al. Among authors: woldeyohannes ho. J Affect Disord. 2017 Mar 1;210:57-65. doi: 10.1016/j.jad.2016.12.006. Epub 2016 Dec 18. J Affect Disord. 2017. PMID: 28013123 Clinical Trial.
The effect of lisdexamfetamine dimesylate on body weight, metabolic parameters, and attention deficit hyperactivity disorder symptomatology in adults with bipolar I/II disorder.
McIntyre RS, Alsuwaidan M, Soczynska JK, Szpindel I, Bilkey TS, Almagor D, Woldeyohannes HO, Powell AM, Cha DS, Gallaugher LA, Kennedy SH. McIntyre RS, et al. Among authors: woldeyohannes ho. Hum Psychopharmacol. 2013 Sep;28(5):421-7. doi: 10.1002/hup.2325. Hum Psychopharmacol. 2013. PMID: 24014142 Clinical Trial.
48 results